Amplifon (AMP.MI)

Overall impact
B (73)

Commentary

Amplifon is a strong overall performer. With a 'B' rating of 72.9 for overall impact (86th percentile compared to all companies), Amplifon ranks 38th out of 155 industry peers, behind American Shared Hospital Services, Accuray, Edap Tms and 34 others, and ahead of Hologic, Avinger, BioSig Technologies and 114 others. On top material causes for Amplifon's industry (Healthcare Equipment), Amplifon performs well in Sanitation Access (81.7 score), Reduced Green House Gas Emissions (81.4), Child and Maternal Health (80.8) and 5 other causes where it received an 'A' score. Amplifon did not receive a 'D' or 'F' rating on any cause.
Impact
Cause AMP.MI
Peer rank
Overall impact

Log in to view this information

Impact trend

Change in rating for overall impact

Log in to view this information

Company
Employees
11,792
Sector
Health Care
Industry
Health Care Providers & Services
Sub-industry
Health Care Equipment
SASB industry
Medical Equipment & Supplies
Headquarters
Mi, Italy
Share classes
AMFPY
ADR
AMP.MI
Description
Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that helps people to rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company operates Ampli-care, a platform to deliver audiological care experience; and Amplifon App to manage the device functions in real-time directly from smartphone. It also offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices. The company was founded in 1950 and is headquartered in Milan, Italy.
Material causes
Ethos considers the following causes material for Amplifon, based on its industry sub-industry Health Care Equipment. Learn more about material causes in our methodology overview.

This information is subject to Ethos' Terms and Conditions, which you can find here.

This information may not be used for corporate financing purposes (including, without limitation, ESG-linked loans, credit facilities, securities or structured products), as a basis for any financial instruments or products (including, without limitation, passively managed funds and index-linked derivative securities) or other products or services, to verify or correct data in any other compilation of data or index, to create any derivative works, nor to create any other data or index (custom or otherwise), without Ethos' prior written permission.

By browsing this site you agree to our use of cookies. Read more.
We use cookies on this site to enhance your user experience. By continuing to browse the site, you are agreeing to our use of cookies. Give me more info.